COASTLANDS CAPITAL LP purchased 3.1% of their position (11.75K shares) of ADIAL PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $32.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/13/2026ACC: 0001104659-26-082972
10% Owner
Since Jun 2026
+11.75K
Net shares
Net buyer
$32.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
11.75K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+10.05K
Price / share
$2.79
Trade value
$28.05K
% of position
2.7%
7/9/2026
373.32K→383.38K
Common Stock
Indirect
Shares
+1.70K
Price / share
$2.70
Trade value
$4.59K
% of position
0.4%
7/10/2026
383.38K→385.07K
Total
Net shares
+11.75K
Net value
$32.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/9/2026 | P · Purchase | +10.05K | $2.79 | $28.05K | 2.7% | 373.32K | 383.38K |
| Common Stock Indirect | 7/10/2026 | P · Purchase | +1.70K | $2.70 | $4.59K | 0.4% | 383.38K | 385.07K |
| Total | +11.75K | $32.64K | ||||||
Derivative Transactions0
No derivative transactions reported